AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.63%35.090.9%$1197.25m
JNJJohnson & Johnson
-0.21%131.250.7%$859.25m
MRKMerck & Co., Inc.
-0.18%86.750.6%$783.59m
ABBVAbbVie, Inc.
-0.04%67.512.3%$640.39m
BMYBristol-Myers Squibb Company
0.15%47.841.4%$636.07m
LLYEli Lilly and Company
0.10%111.571.0%$423.54m
AZNAstraZeneca PLC Sponsored ADR
0.02%45.431.2%$175.47m
NVSNovartis AG Sponsored ADR
-1.24%89.000.2%$174.32m
GSKGlaxoSmithKline plc Sponsored ADR
0.71%40.980.3%$96.41m
NVONovo Nordisk A/S Sponsored ADR Class B
1.70%52.700.1%$74.69m
SNYSanofi Sponsored ADR
-1.46%42.570.2%$48.72m
LCILannett Company, Inc.
-2.56%6.8436.6%$4.66m
AKTXAkari Therapeutics Plc Sponsored ADR
-4.81%1.781.6%$3.40m
EPIXESSA Pharma Inc
-5.26%1.800.1%$0.04m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.